ArticleObesity surgery2021
Effects of Bariatric Surgery on COVID-19: a Multicentric Study from a High Incidence Area.
Article in Obesity surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- Impact of prior bariatric surgery on risk and severity of COVID-19 infection: A meta-analysis of observational studies.Obesity research & clinical practicePooled it
- Effects of Weight Loss on Adipose and Muscular Neuropilin 1 mRNA Expression in Obesity: Potential Implication in SARS-CoV-2 Infections?Obesity facts · 2022Trial
- The EPICOVID19-BS study: a web-based epidemiological survey in bariatric patients.Journal of endocrinological investigation · 2025Observational
- The Association of Weight Reduction and Other Variables after Bariatric Surgery with the Likelihood of SARS-CoV-2 Infection.Journal of clinical medicine · 2023Article
- Prior metabolic surgery reduced COVID-19 severity: Systematic analysis from year one of the COVID-19 pandemic.Heliyon · 2023Article
- Knowledge, Attitudes and Practices towards SARS-CoV-2 vaccination among morbid obese individuals: a pilot study.Acta bio-medica : Atenei Parmensis · 2022Article
- Is COVID-19 Severity Impacted by Bariatric Surgery in the Early Postoperative Period?Obesity surgery · 2022Article
- Early COVID-19 Vaccine Hesitancy Characteristics in Mothers Following Bariatric Surgery.Obesity surgery · 2022Article
- COVID-19 Vaccination and Timing of Bariatric Surgery: Considerations and Concerns for Patients with Severe Obesity.Obesity surgery · 2022Article
- Role of bariatric surgery in a COVID-19 era: a review of economic costs.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2021Review
- Letter to the Editor on Type 1 diabetes onset triggered by COVID-19.Acta diabetologica · 2021Article
- Effects of Bariatric Surgery on Influenza-Like Illness: a Two-Center Cross-sectional Study.Obesity surgery · 2021Article
- SARS-CoV-2 Seroprevalence Post-First Wave among Primary Care Physicians in Catania (Italy).Tropical medicine and infectious disease · 2021Article
Corrections and comments
- Commented on by
Authors and funding
21 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe favorable effects of bariatric surgery (BS) on overall pulmonary function and obesity-related comorbidities could influence SARS-CoV-2 clinical expression. This has been investigated comparing COVID-19 incidence and clinical course between a cohort of patients submitted to BS and a cohort of candidates for BS during the spring outbreak in Italy. MATERIALS AND
methodsFrom April to August 2020, 594 patients from 6 major bariatric centers in Emilia-Romagna were administered an 87-item telephonic questionnaire. Demographics, COVID-19 incidence, suggestive symptoms, and clinical outcome parameters of operated patients and candidates to BS were compared. The incidence of symptomatic COVID-19 was assessed including the clinical definition of probable case, according to World Health Organization criteria.
resultsThree hundred fifty-three operated patients (Op) and 169 candidates for BS (C) were finally included in the statistical analysis. While COVID-19 incidence confirmed by laboratory tests was similar in the two groups (5.7% vs 5.9%), lower incidence of most of COVID-19-related symptoms, such as anosmia (p: 0.046), dysgeusia (p: 0.049), fever with rapid onset (p: 0.046) were recorded among Op patients, resulting in a lower rate of probable cases (14.4% vs 23.7%; p: 0.009). Hospitalization was more frequent in C patients (2.4% vs 0.3%, p: 0.02). One death in each group was reported (0.3% vs 0.6%). Previous pneumonia and malignancies resulted to be associated with symptomatic COVID-19 at univariate and multivariate analysis.
conclusionPatients submitted to BS seem to develop less severe SARS-CoV-2 infection than subjects suffering from obesity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.